Skip to main content

Biomarin Pharmaceuticals (NQ: BMRN )

88.61 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
February 19, 2018
Form 5
Source: SEC/Edgar
February 13, 2018
Form 5
Source: SEC/Edgar
February 13, 2018
Form 5
Source: SEC/Edgar
February 13, 2018
Form 5
Source: SEC/Edgar
February 13, 2018
Form 4
Source: SEC/Edgar
February 04, 2018
Form 4
Source: SEC/Edgar
January 08, 2018
Form 4
Source: SEC/Edgar
January 03, 2018
Form 4
Source: SEC/Edgar
January 03, 2018
Form 4
Source: SEC/Edgar
January 01, 2018
Form 4
Source: SEC/Edgar
December 17, 2017
Form 4
Source: SEC/Edgar
December 03, 2017
Form 4/A
Source: SEC/Edgar
October 12, 2017
Form 4/A
Source: SEC/Edgar
October 12, 2017
Form 4/A
Source: SEC/Edgar
October 12, 2017
Form 4/A
Source: SEC/Edgar
October 12, 2017
Form 4/A
Source: SEC/Edgar
October 12, 2017
Form 3
Source: SEC/Edgar
October 02, 2017
Form 4
Source: SEC/Edgar
October 02, 2017
Form 4
Source: SEC/Edgar
October 01, 2017
Form 4
Source: SEC/Edgar
September 25, 2017
Form 4
Source: SEC/Edgar
May 16, 2017
Form 4
Source: SEC/Edgar
May 16, 2017
Form 4
Source: SEC/Edgar
May 16, 2017
Form 4
Source: SEC/Edgar
May 16, 2017
Form 4
Source: SEC/Edgar
May 16, 2017
Form 4
Source: SEC/Edgar
May 16, 2017
Form 4
Source: SEC/Edgar
May 16, 2017
Form 4
Source: SEC/Edgar
April 05, 2017
Form 4
Source: SEC/Edgar
March 23, 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.